Conflicts of interest
AM-V, PAP, IL, LB, EM, AM-Y, SM-Y, and LR-P received honoraria compensation to participate in advisory boards, collaborations as a consultant, and scientific communications, and received research support and funding for travel and congress expenses from Biogen Idec, Novartis, TEVA, BMS, Horizon, Merck Serono, Genzyme, Almirall, Bial, Kern Pharma, Lilly, Sanofi, Bayer, and Roche.